| Unique ID issued by UMIN | UMIN000056720 |
|---|---|
| Receipt number | R000064826 |
| Scientific Title | A study of the effect of food ingredient on cerebral blood flow. (SIC-2023-06-3IN1) |
| Date of disclosure of the study information | 2025/02/21 |
| Last modified on | 2025/07/23 09:40:08 |
A study of the effect of food ingredient on cerebral blood flow. (SIC-2023-06-3IN1)
A study of the effect of food ingredient on cerebral blood flow. (SIC-2023-06-3IN1)
A study of the effect of food ingredient on cerebral blood flow. (SIC-2023-06-3IN1)
A study of the effect of food ingredient on cerebral blood flow. (SIC-2023-06-3IN1)
| Japan |
Healthy adults
| Adult |
Others
NO
To study the effect of food ingredients on cerebral blood flow.
Efficacy
Cerebral blood flow
Interventional
Parallel
Randomized
Individual
Double blind -all involved are blinded
Placebo
2
Prevention
| Food |
Ingredient A-containing food (40 weeks)
Ingredient-free food (40 weeks)
| 60 | years-old | <= |
| 75 | years-old | > |
Male and Female
(1)Subjects who can make self-judgment and are voluntarily giving written informed consent.
(2)From 60 to 75 years healthy men and women
(1)Subjects who are under medication for dementia, Alzheimer's disease, psychiatric disorder and cerebrovascular disease.
(2)Subjects who have a history or are suspected patient of cranial nerve disease and psychiatric disorders.
(3)Subjects who have serious cerebrovascular, cardiac, hepatic, renal, gastrointestinal diseases, and/or affected with infectious diseases requiring reports to the authorities.
(4)Subjects who are with diabetes mellitus.
(5)Subjects who have major surgical history relevant to the digestive system such as gastrectomy, gastrointestinal suture, or intestinal resection.
(6)Subjects who are with systolic blood pressure of less than 90 mmHg.
(7)Subjects who have unusually high and/or low blood pressure and/or abnormal hematological data.
(8)Pre- or post-menopausal women complaining of obvious physical changes.
(9)Subjects who have had an abnormal electrocardiogram.
(10)Subjects who have had abnormal tumor marker values.
(11)Subjects who have had cognitive dysfunctions.
(12)Subjects with impaired renal function on the screening test
(13)Subjects with impaired liver function on the screening test
(14)Subjects who have difficulty swallowing
100
| 1st name | Yumi |
| Middle name | |
| Last name | Nakamura |
Suntory global innovation center limited.
Research Institute
619-0284
8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto, JAPAN
050-1804-0762
Yumi_Nakamura@suntory.co.jp
| 1st name | Kentaro |
| Middle name | |
| Last name | Nishioka |
Suntory global innovation center limited.
Research Institute
619-0284
8-1-1 Seikadai, Seika-cho, Soraku-gun, Kyoto, JAPAN
050-1804-1054
Kentaro_Nishioka@suntory.co.jp
Hokkaido Information University
Suntory Holdings limited.
Profit organization
The ethics committee of Hokkaido Information University
59-2, Nishi-nopporo, Ebetsu, Hokkaido, 069-8585, Japan
011-385-4411
soumu@do-johodai.ac.jp
NO
| 2025 | Year | 02 | Month | 21 | Day |
Unpublished
No longer recruiting
| 2024 | Year | 12 | Month | 20 | Day |
| 2024 | Year | 12 | Month | 20 | Day |
| 2025 | Year | 02 | Month | 21 | Day |
| 2026 | Year | 03 | Month | 21 | Day |
| 2025 | Year | 01 | Month | 15 | Day |
| 2025 | Year | 07 | Month | 23 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000064826